Literature DB >> 28008838

[The role of intestinal microbiota in the response to anti-tumor therapies].

Marie Vétizou1, Romain Daillère1, Laurence Zitvogel1.   

Abstract

The gut microbiota is involved in a lot of crucial physiological functions and maintains a symbiotic relationship with the host. Lately, in light of new evidences, an unexpected role of commensals has been depicted. Several studies addressing the role of gut microbiota in the immunomodulatory properties of anti-cancer regimens, such as immunotherapy and chemotherapy, reveal that commensals are required to mount complete and efficient antitumor immune responses. Therefore, exploration of microbiota-derived compounds in the future could represent a therapeutic option in the armamentarium of cancer treatments.
© 2016 médecine/sciences – Inserm.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 28008838     DOI: 10.1051/medsci/20163211013

Source DB:  PubMed          Journal:  Med Sci (Paris)        ISSN: 0767-0974            Impact factor:   0.818


  6 in total

Review 1.  How Could Antibiotics, Probiotics, and Corticoids Modify Microbiota and Its Influence in Cancer Immune Checkpoint Inhibitors: A Review.

Authors:  Mara Cruellas; Alfonso Yubero; María Zapata; Eva M Galvez; Marta Gascón; Dolores Isla; Rodrigo Lastra; Luis Martínez-Lostao; Maitane Ocariz; Julián Pardo; Ariel Ramírez; Andrea Sesma; Irene Torres-Ramón; José Ramón Paño
Journal:  Infect Immun       Date:  2021-08-16       Impact factor: 3.441

2.  Gut microbiota modulate dendritic cell antigen presentation and radiotherapy-induced antitumor immune response.

Authors:  Mireia Uribe-Herranz; Stavros Rafail; Silvia Beghi; Luis Gil-de-Gómez; Ioannis Verginadis; Kyle Bittinger; Sergey Pustylnikov; Stefano Pierini; Renzo Perales-Linares; Ian A Blair; Clementina A Mesaros; Nathaniel W Snyder; Frederic Bushman; Constantinos Koumenis; Andrea Facciabene
Journal:  J Clin Invest       Date:  2020-01-02       Impact factor: 19.456

Review 3.  Intestinal microbiota: a new force in cancer immunotherapy.

Authors:  Zhujiang Dai; Jingqiu Zhang; Qi Wu; Huiwen Fang; Chunfeng Shi; Zhen Li; Chaobiao Lin; Dong Tang; Daorong Wang
Journal:  Cell Commun Signal       Date:  2020-06-10       Impact factor: 5.712

Review 4.  Intestinal Microbiota: The Driving Force behind Advances in Cancer Immunotherapy.

Authors:  Zhujiang Dai; Jihong Fu; Xiang Peng; Dong Tang; Jinglue Song
Journal:  Cancers (Basel)       Date:  2022-09-30       Impact factor: 6.575

Review 5.  Gut microbiome modulates efficacy of immune checkpoint inhibitors.

Authors:  Ming Yi; Shengnan Yu; Shuang Qin; Qian Liu; Hanxiao Xu; Weiheng Zhao; Qian Chu; Kongming Wu
Journal:  J Hematol Oncol       Date:  2018-03-27       Impact factor: 17.388

Review 6.  A new biological triangle in cancer: intestinal microbiota, immune checkpoint inhibitors and antibiotics.

Authors:  Jie Zhang; Zhujiang Dai; Cheng Yan; Wenjie Zhang; Daorong Wang; Dong Tang
Journal:  Clin Transl Oncol       Date:  2021-06-14       Impact factor: 3.405

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.